Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1998-5-22
|
| pubmed:abstractText |
The prognosis of cholesterol embolism is often poor, and no treatment is presently available. We report the use of a stable prostacyclin analogue in treating cholesterol embolism in a diabetic patient with arteriopathy. As a sole therapy, it improved cutaneous manifestations and pain, in parallel with an increased transcutaneous oxymetry. We think that prostacyclin analogues are novel candidates for the treatment of cholesterol embolism.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0742-3071
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
15
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
262-3
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9545130-Aged,
pubmed-meshheading:9545130-Crystallization,
pubmed-meshheading:9545130-Diabetes Mellitus, Type 2,
pubmed-meshheading:9545130-Diabetic Angiopathies,
pubmed-meshheading:9545130-Embolism, Cholesterol,
pubmed-meshheading:9545130-Humans,
pubmed-meshheading:9545130-Iloprost,
pubmed-meshheading:9545130-Male
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Use of a prostacyclin analogue in cholesterol crystal embolism.
|
| pubmed:affiliation |
Department of Metabolic Diseases, CHU Lapeyronie, Montpellier, France.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|